More than 14,490 people in the U.S. will be diagnosed with glioblastoma in 2023, according to the National Brain Tumor Society, and 10,000 people in the U.S. will die of the disease. The five-year survival rate is 6.9%, and ...
Jul 22, 2023
0
2
One in eight women will develop breast cancer in their lifetime. The disease is treatable, especially when caught early. But what is the impact of breast cancer later in life? A Moffitt Cancer Center researcher, in collaboration ...
Jul 19, 2023
0
26
Preoperative and postoperative models are highly accurate for predicting breast cancer-related lymphedema (BCRL), according to a study published online July 12 in JAMA Surgery.
Jul 14, 2023
0
38
For most of our tissues and cells, a lack of oxygen, or hypoxia, is bad news. Cancer cells, on the other hand, can thrive in these hypoxic conditions, which render tumors less susceptible to anti-cancer treatments, including ...
Jul 10, 2023
0
1
A local study led by the Agency for Science, Technology and Research (A*STAR) discovered that by inhibiting the function of two proteins, G9a and GLP, during the cell therapy production process, immune cells could become ...
Jul 10, 2023
0
59
Radiation therapy is a common treatment used to kill cancerous cells. However, healthy cells also sustain damage during the lengthy treatment process. FLASH is a targeted radiation therapy that kills tumor cells while sparing ...
Jul 10, 2023
0
1
Researchers from The University of Texas MD Anderson Cancer Center found the KRAS G12C inhibitor adagrasib showed promising activity suppressing cancer growth not only within the lungs but also in brain metastases for patients ...
Jun 16, 2023
0
28
One in two men and one in three women in the U.S. will be diagnosed with cancer in their lifetime, and more than 18 million cancer survivors are alive today, according to the American Cancer Society.
Jun 13, 2023
0
2
Oncologists have traditionally prescribed androgen deprivation therapy (ADT) alone for patients with metastatic hormone-sensitive prostate cancer (mHSPC).
Jun 9, 2023
0
9
The American Society for Radiation Oncology (ASTRO) Gastrointestinal Cancers Resource Panel issued the following statement today regarding the PROSPECT clinical trial for patients with rectal cancer:
Jun 7, 2023
0
29
